###begin article-title 0
###xml 28 49 28 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oryctolagus cuniculus</italic>
###xml 20 26 <span type="species:ncbi:9986">Rabbit</span>
###xml 28 49 <span type="species:ncbi:9986">Oryctolagus cuniculus</span>
Investigations of a Rabbit (Oryctolagus cuniculus) Model of Systemic Lupus Erythematosus (SLE), BAFF and Its Receptors
###end article-title 0
###begin p 1
Conceived and designed the experiments: JY RGM. Performed the experiments: JY RP SR JM. Analyzed the data: JY RP SR JM RGM. Contributed reagents/materials/analysis tools: RGM. Wrote the paper: JY RP RGM.
###end p 1
###begin p 2
###xml 445 466 445 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oryctolagus cuniculus</italic>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 437 443 <span type="species:ncbi:9986">rabbit</span>
###xml 445 466 <span type="species:ncbi:9986">Oryctolagus cuniculus</span>
###xml 564 571 <span type="species:ncbi:9986">rabbits</span>
###xml 654 661 <span type="species:ncbi:9986">rabbits</span>
###xml 1299 1306 <span type="species:ncbi:9986">rabbits</span>
###xml 1318 1325 <span type="species:ncbi:9986">rabbits</span>
###xml 1530 1537 <span type="species:ncbi:9986">rabbits</span>
###xml 1688 1695 <span type="species:ncbi:9986">rabbits</span>
###xml 1731 1737 <span type="species:ncbi:9986">rabbit</span>
###xml 1764 1769 <span type="species:ncbi:9606">human</span>
###xml 1831 1837 <span type="species:ncbi:9986">rabbit</span>
###xml 1878 1883 <span type="species:ncbi:9606">Human</span>
###xml 2143 2150 <span type="species:ncbi:9986">rabbits</span>
###xml 2251 2257 <span type="species:ncbi:9986">rabbit</span>
B-cell activation factor belonging to the tumor necrosis factor family (BAFF) is a major contributor to survival of B lymphocytes during development and maturation. A relationship between circulating BAFF levels and disease activity has been reported in patients with the autoimmune disease Systemic Lupus Erythematosus (SLE). Clinical trials targeting BAFF or its receptors are currently in progress. In order to further characterize a rabbit (Oryctolagus cuniculus) model of SLE, we investigated the expression of BAFF and its receptors in non-inbred, pedigreed rabbits derived from breeding and selection based on autoantibody responses. We immunized rabbits related to previous groups that developed autoantibodies and inflammatory responses after immunizations with peptides synthesized on multiple antigen-branched polylysine backbones. Blood and sera collected before immunization and after boosts were used for health monitoring, analyses of serum autoantibody responses by ELISA and immunofluorescence. Peripheral blood mononuclear cells (PBMC) were studied by flow cytometry and were the source of mRNA for quantitative PCR analyses. We hypothesized that BAFF mRNA expression and serum BAFF levels measured indirectly through BAFF receptor binding might increase in autoantibody-producing rabbits. Immunized rabbits developed elevated levels of leucocyte populations, anti-nuclear, anti-dsDNA and other autoantibodies. BR3 mRNA levels in total PBMC decreased and BAFF levels remained low and unchanged in most immunized rabbits. By flow cytometry, percentages of BAFF positive cells decreased. Percentages of transmembrane activator and CAML interactor (TACI) decreased in most rabbits from all the immunized groups. The rabbit is an important model for human autoimmune and infectious diseases, and a high quality draft rabbit genome assembly was recently completed. Human disease models developed in non-inbred pedigreed animals are better able to reflect the complexities of diseases such as SLE with familial patterns of inheritance. Although no consistent pattern of elevated expression of BAFF mRNA or protein was found in the rabbits studied, the data collected and reported here build upon previous data to refine understanding of a rabbit model of SLE.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 615 618 615 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Ardoin1">[1]</xref>
###xml 620 623 620 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Cancro1">[2]</xref>
###xml 680 683 680 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-PegoReigosa1">[3]</xref>
###xml 685 688 685 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Ding1">[4]</xref>
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with considerable heterogeneity in clinical manifestations and disease course. Although multiple immunologic abnormalities contribute to the development of SLE, it is generally accepted that B cells play key roles in disease pathogenesis. B cells are responsible for tissue damage both by generating autoantibody-producing cells and through other indirect mechanisms that may break T cell tolerance. Understanding the factors that control the survival of these pathological B cells is essential for elucidating the pathogenesis of SLE (reviewed in [1], [2]) and providing new targets for SLE therapy (reviewed in [3], [4]).
###end p 4
###begin p 5
###xml 78 81 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-James1">[6]</xref>
###xml 617 620 617 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 825 828 825 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-DeGiorgio1">[7]</xref>
###xml 830 833 830 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Diamond1">[8]</xref>
###xml 1087 1090 1087 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 1177 1180 1177 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 70 77 <span type="species:ncbi:9986">rabbits</span>
###xml 570 576 <span type="species:ncbi:9986">rabbit</span>
###xml 846 853 <span type="species:ncbi:9986">rabbits</span>
###xml 1004 1009 <span type="species:ncbi:9606">human</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
###xml 1030 1037 <span type="species:ncbi:9986">rabbits</span>
###xml 1271 1278 <span type="species:ncbi:9986">rabbits</span>
###xml 1359 1365 <span type="species:ncbi:9986">rabbit</span>
Our laboratory described a model of SLE in NIAID-pedigreed non-inbred rabbits [5], based on earlier reports of James et al. [6] that Multiple Antigen Peptide (MAP-8) immunogens elicited lupus-like autoantibody responses. Their immunogen carried eight copies of a peptide sequence derived from EBV EBNA1 protein with sequence similarity to spliceosomal SmB/B' protein Smith (Sm) autoantigen. We confirmed their observation of autoantibody responses following immunization and boosting with the same peptide antigen and extended the work by immunizing with a peptide from rabbit N-methyl-D-aspartate receptor NR2b (GR) [5]. Cross reactivity of some anti-dsDNA autoantibodies with this important receptor led to the suggestion that such cross reactive anti-dsDNA antibodies play a role in neuropsychiatric manifestations of SLE [7], [8]. All of the rabbits produced peptide-specific antibodies and some also produced autoantibodies including anti-dsDNA and anti-nuclear antibodies resembling those found in human lupus patients. Two rabbits experienced seizures and one developed nystagmus [5]. Heterogeneity of responses was confirmed in further investigations by Puliyath et al [9] who used the GR-MAP-8 peptide to immunize animals selectively bred from earlier responder rabbits and provided evidence for genetic contributions to autoantibody profiles in the rabbit model of SLE.
###end p 5
###begin p 6
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Treml1">[10]</xref>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Sakurai1">[11]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-OConnor1">[12]</xref>
###xml 1270 1274 1270 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Groom1">[13]</xref>
###xml 962 966 <span type="species:ncbi:10090">mice</span>
###xml 993 1008 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 1070 1075 <span type="species:ncbi:9606">human</span>
###xml 1153 1158 <span type="species:ncbi:10090">mouse</span>
B-cell activating factor (BAFF; also termed BLyS, CD257, TNFSF13B, TALL-1, and zTNF4) is a potent B cell survival factor mainly expressed by myeloid cells and monocyte-derived dendritic cells. Receptors with distinct developmental and functional roles are the BAFF receptor (BR3 also termed BAFF-R), the transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI) and the B cell maturation antigen (BCMA) (reviewed in [10]). TACI and BCMA bind both BAFF and APRIL, another TNF ligand superfamily member. TACI plays a role in negatively regulating mature B-cell homeostasis, but TACI also plays a role in T-independent B-cell responses and class switch recombination [11]. Recent reports suggest a role of BCMA in controlling the lifespan of long-lived plasma cells [12]. The numbers of mature B cells in secondary lymphoid organs, baseline serum Ig levels and Ig responses to T-cell-dependent and -independent antigens, are reduced in mice that cannot express BAFF. Transgenic mice that over express BAFF develop autoimmune disease resembling human lupus. Although T cells are not required for the disease development in this mouse model, innate immune signals through MyD88 are required for B cell activation and production of autoantibodies [13].
###end p 6
###begin p 7
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Petri1">[14]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Ju1">[15]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Furie1">[16]</xref>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Cancro2">[17]</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Ding2">[18]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Petri1">[14]</xref>
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Ju1">[15]</xref>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 177 185 <span type="species:ncbi:9606">patients</span>
###xml 409 415 <span type="species:ncbi:9986">rabbit</span>
###xml 480 485 <span type="species:ncbi:9606">human</span>
###xml 624 629 <span type="species:ncbi:9606">Human</span>
###xml 840 848 <span type="species:ncbi:9606">patients</span>
Disease activity in human lupus patients has been reported to correlate with serum BAFF levels (reviewed in [14]) and levels of expression of BAFF, TACI and BR3 mRNA in PBMC of patients with SLE were reported to be significantly elevated [15]. Clinical trials targeting BAFF or its receptors are currently in progress [16]; (also reviewed in [17], [18]). We chose to investigate BAFF and its receptors in the rabbit SLE model because of their potential as therapeutic targets for human SLE and the reported correlations of disease activity with elevated serum BAFF protein [14] and BAFF mRNA in PBMC [15]. On July 20, 2009, Human Genome Sciences and GlaxoSmithKline announced that a placebo-controlled BLISS-52 study of BENLYSTAtrade mark (belimumab, formerly LymphoStat-B(R)) met the primary endpoint in the first of two Phase 3 trials in patients with serologically active SLE. See: .
###end p 7
###begin p 8
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Yang1">[19]</xref>
###xml 417 418 417 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 471 472 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 587 588 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 835 836 835 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Yang1">[19]</xref>
###xml 82 88 <span type="species:ncbi:9986">rabbit</span>
###xml 148 154 <span type="species:ncbi:9986">rabbit</span>
###xml 239 245 <span type="species:ncbi:9986">rabbit</span>
###xml 332 338 <span type="species:ncbi:9986">rabbit</span>
###xml 922 928 <span type="species:ncbi:9986">rabbit</span>
###xml 1006 1012 <span type="species:ncbi:9986">rabbit</span>
Before initiating this investigation of the role of BAFF and its receptors in the rabbit model of SLE, we first studied expression and localization rabbit BAFF and its specific high affinity receptor BR3 in cells and tissues of the normal rabbit immune system [19]. We found that mRNA for both BAFF and BR3 was detectable in normal rabbit peripheral blood mononuclear cells (PBMC). BAFF message was detectable in CD14+ macrophage/monocyte populations as well as some CD14- cell populations from peripheral blood and spleen. We found high levels of mRNA for BR3 in normal unstimulated IgM+ B cells but they did not have detectable BAFF message. Since surface BAFF was detected by flow cytometry and immunohistochemical staining even though no mRNA was detected, we suggested that soluble BAFF was probably bound to BAFF receptors on IgM+ B cells. We also detected BAFF by immunohistochemical studies of developing neonatal rabbit appendix and suggested that BAFF could play a role in early stages of normal rabbit B-cell development [19].
###end p 8
###begin p 9
###xml 139 146 <span type="species:ncbi:9986">rabbits</span>
###xml 205 211 <span type="species:ncbi:9986">rabbit</span>
###xml 736 743 <span type="species:ncbi:9986">rabbits</span>
###xml 994 1000 <span type="species:ncbi:9986">rabbit</span>
Based on this initial groundwork, we set out to investigate BAFF and its receptors during B-cell activation and autoantibody production in rabbits derived from selective breeding to develop a reproducible rabbit model of SLE. Flow cytometry was used to detect BAFF, BR3 and TACI on PBMC prior to and after immunization and boosting in order to seek associations of levels of BAFF, BR3 and TACI with autoantibodies detected in serum and hematological changes in blood. Quantitative PCR was used to detect expression of BAFF and BR3 in PBMC prior to and after immunization and boosting. In addition, beta2-microglobulin (B2M) mRNA expression was measured because it was found in earlier studies to be elevated in expression in some lupus rabbits (Rai et al. ms in preparation). Increased levels of B2M reflect elevated levels of class I MHC molecules in activated PBMC. This study broadens our knowledge of the expression of this important member of the TNF superfamily in a non-inbred pedigreed rabbit model of SLE where BAFF may specifically regulate B- lymphocyte proliferation and survival.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin title 11
Animals
###end title 11
###begin p 12
###xml 581 584 581 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh</italic>
###xml 596 601 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 646 650 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Mage1">[20]</xref>
###xml 669 676 661 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t001">Table 1</xref>
###xml 220 228 <span type="species:ncbi:3607">Woodbine</span>
###xml 268 274 <span type="species:ncbi:9986">rabbit</span>
###xml 294 301 <span type="species:ncbi:9986">Rabbits</span>
###xml 682 689 <span type="species:ncbi:9986">rabbits</span>
###xml 829 835 <span type="species:ncbi:9986">rabbit</span>
###xml 837 839 <span type="species:ncbi:9986">CF</span>
The animal studies described here were reviewed and approved by the animal care and use committees of NIAID/National Institutes of Health, Bethesda, MD (animal study protocol LI-6) and of the Spring Valley Laboratories (Woodbine, MD), where the NIAID allotype-defined rabbit colony was housed. Rabbits of the experimental group were relatives and descendants bred and developed from the previous lupus experimental groups, based on autoantibody responses. The animals' designations, sexes, ages at the start of the experiment, immunoglobulin allotypes including VHa encoded at the Igh locus and Ckappab encoded at the light chain (Ckappa1) locus [20] are summarized in Table 1. The rabbits were divided into four groups (A, B, C, and D) to allow handling of blood for preparation of PBMC for FACS and mRNA isolation. One control rabbit (CF) in group C died and was not replaced.
###end p 12
###begin title 13
###xml 10 17 <span type="species:ncbi:9986">rabbits</span>
Immunized rabbits, sexes, Ig allotypes and ages.
###end title 13
###begin title 14
Pedigree analysis
###end title 14
###begin p 15
###xml 106 108 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
Breeding information and experimental records on the breeding colony were entered into a custom designed 4th Dimension relational database (Tiller systems, Brunswick, MD). Information from the database was exported into Pedigree-Draw for generation of pedigrees (Jurek Software, Cottage Grove WI).
###end p 15
###begin title 16
Antigens
###end title 16
###begin p 17
###xml 65 71 <span type="species:ncbi:9986">rabbit</span>
###xml 364 371 <span type="species:ncbi:9986">rabbits</span>
###xml 373 375 <span type="species:ncbi:9986">CF</span>
###xml 422 425 <span type="species:ncbi:31658">CFA</span>
The peptide sequence (DEWDYGLP) from the extracellular domain of rabbit neuronal postsynaptic glutamate receptor N-methyl-D-aspartate (NMDA) NR2b chain (peptide GR) was synthesized on a multiple antigen-branched polylysine (multiple antigen peptide) (MAP) backbone (BB). BB-MAP-8 without peptide was synthesized as control immunogen. In addition, adjuvant control rabbits (CF) received initial Complete Freund's Adjuvant (CFA) followed by boosts with Incomplete Freund's Adjuvant (IFA) emulsified with the same diluent used for the antigens. All synthesized structures were analyzed by HPLC (National Institutes of Health Peptide Synthesis and Analysis Unit, Research Technology Branch, Rockville, MD).
###end p 17
###begin title 18
Immunization
###end title 18
###begin p 19
###xml 5 11 <span type="species:ncbi:9986">rabbit</span>
###xml 82 89 <span type="species:ncbi:9986">rabbits</span>
###xml 107 114 <span type="species:ncbi:9986">rabbits</span>
###xml 197 200 <span type="species:ncbi:31658">CFA</span>
###xml 310 313 <span type="species:ncbi:31658">CFA</span>
###xml 316 318 <span type="species:ncbi:9986">CF</span>
###xml 319 326 <span type="species:ncbi:9986">rabbits</span>
###xml 329 336 <span type="species:ncbi:9986">Rabbits</span>
###xml 522 529 <span type="species:ncbi:9986">rabbits</span>
###xml 1082 1089 <span type="species:ncbi:9986">rabbits</span>
Each rabbit received initial subcutaneous (s.c.) injection of either GR-MAP-8 (GR rabbits), control BB (BB rabbits) (0.5 mg/0.5 ml in borate-buffered saline pH 8.0 (BBS), emulsified with 0.5 ml of CFA), or control borate buffered saline, pH 8.0 (BBS) (0.5 ml of BBS, with 0.5 ml of complete Freund's adjuvant (CFA) (CF rabbits). Rabbits received either 3 or 5 boosts given s.c. at 3-wk intervals with the same antigen concentration or BBS) emulsified with incomplete Freund's adjuvant (IFA). After the final boost in IFA, rabbits were injected intravenously (i.v.) 3 weeks later with the same antigen concentration or BBS. Sera and heparinized whole blood cells were collected immediately before immunization (pre-immune) and 1 wk after each boost (post-boost). Sera were aliquoted and stored at -20degreesC for assay. A sample of whole blood was collected for complete blood cell and chemistry analysis, and the remaining blood used for PBMC isolation for flow cytometry analysis and mRNA. Blood for chemistry, hematology and PBMC for mRNA analyses was collected a week later, and rabbits euthanized 7 or 8 days after the final i.v. boost.
###end p 19
###begin title 20
Clinical assessment
###end title 20
###begin p 21
###xml 298 301 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 303 306 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 4 11 <span type="species:ncbi:9986">rabbits</span>
The rabbits were regularly monitored for clinical signs of disease and subjected to periodic health examinations. Whole blood and sera collected after boosts were sent to a veterinary diagnostic laboratory (Antech Diagnostics) for complete blood counts and chemistry panels as previously described [5], [9].
###end p 21
###begin title 22
ELISA for anti-peptide antibodies, anti-dsDNA and autoantibodies to nuclear antigens
###end title 22
###begin p 23
###xml 1106 1109 1058 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 688 692 <span type="species:ncbi:9925">goat</span>
###xml 698 704 <span type="species:ncbi:9986">rabbit</span>
###xml 909 914 <span type="species:ncbi:9606">human</span>
###xml 990 994 <span type="species:ncbi:9913">calf</span>
###xml 1134 1140 <span type="species:ncbi:9986">rabbit</span>
###xml 1347 1351 <span type="species:ncbi:9925">goat</span>
###xml 1357 1363 <span type="species:ncbi:9986">rabbit</span>
Serum antibody responses to the GR-MAP-8 and control immunogens were measured by standard solid-phase ELISA. Polystyrene 96-well plates (Corning; catalog no. 3590) were coated with 50 microl/well of GR-MAP-8 at 10 microg/ml in bicarbonate buffer (pH 9.6) and incubated overnight at 4degreesC. Plates were washed three times with PBS (pH 7.2) containing 0.1% Tween 20 and blocked with 100 microl of blocking solution for 1 h at 37degreesC (Quality Biologicals). Wells were then incubated 1 h at 37degreesC with 50 microl/well of 1/1024-diluted sera, washed five times, incubated for 1 h at 37degreesC with 50 microl of a 1/2000 dilution (0.4 ng/microl) of affinity-purified HRP-conjugated goat anti-rabbit IgG (H + L) secondary antibody (Jackson ImmunoResearch Laboratories), developed with 3,3', 5,5'-tetramethylbenzidine (TMB) (INOVA Diagnostics), and the resulting OD read at 450 nm. Commercially available human diagnostic kits (INOVA Diagnostics) were used to assay serum antibodies to calf thymus dsDNA and autoantibodies to nuclear antigens (ANA), and components (Sm and RNP) as previously described [9]. Briefly, 100 microl of rabbit sera diluted 1/41 in the proprietary sample diluents were added to antigen-coated wells and incubated for 30 min at RT. Wells were then washed, incubated for 30 min at RT with 1/8000 diluted HRP-conjugated goat anti-rabbit IgG Fc (Jackson ImmunoResearch Laboratories), and developed with TMB for reading OD at 450 nm.
###end p 23
###begin title 24
Antibodies and reagents for flow cytometry
###end title 24
###begin p 25
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Yang1">[19]</xref>
###xml 65 69 <span type="species:ncbi:9925">goat</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 129 135 <span type="species:ncbi:9986">rabbit</span>
###xml 183 187 <span type="species:ncbi:9925">goat</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 247 253 <span type="species:ncbi:9986">rabbit</span>
###xml 339 343 <span type="species:ncbi:9925">goat</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
###xml 396 402 <span type="species:ncbi:9986">rabbit</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
###xml 466 472 <span type="species:ncbi:9986">rabbit</span>
###xml 530 534 <span type="species:ncbi:9925">goat</span>
###xml 540 546 <span type="species:ncbi:9986">rabbit</span>
###xml 603 609 <span type="species:ncbi:9793">donkey</span>
###xml 615 619 <span type="species:ncbi:9925">goat</span>
###xml 640 644 <span type="species:ncbi:9925">goat</span>
###xml 657 661 <span type="species:ncbi:9925">goat</span>
###xml 727 732 <span type="species:ncbi:10090">mouse</span>
Surface staining for BAFF was determined using biotin-conjugated goat anti-human BAFF polyclonal antibody that cross-reacts with rabbit BAFF; staining for TACI used biotin-conjugated goat anti-human TACI polyclonal antibody that cross-reacts with rabbit TACI (Antigenix, America, Inc.). Surface staining of BR3 was detected using purified goat anti-human BR3 antibody that is cross-reactive with rabbit BR3 (R&D systems) [19]. Also used were FITC-labeled mouse anti-rabbit CD14 (clone K4) (Antigenix, America, Inc.), FITC-labeled goat anti-rabbit IgM (Southern Biotechnology Associates), biotin-labeled donkey anti-goat IgG, biotin-labeled goat IgG, normal goat IgG (Jackson ImmunoResearch Laboratories, Inc), and FITC-labeled mouse IgG2a (BD Pharmingen). Biotinylated antibodies were visualized by PE-conjugated streptavidin (Jackson ImmunoResearch Laboratories, Inc).
###end p 25
###begin title 26
Detection of anti-nuclear antibodies (ANA) by indirect immunofluorescence
###end title 26
###begin p 27
###xml 611 615 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-vonMhlen1">[21]</xref>
###xml 99 105 <span type="species:ncbi:9986">rabbit</span>
###xml 134 138 <span type="species:ncbi:9925">goat</span>
###xml 331 335 <span type="species:ncbi:9925">goat</span>
###xml 341 347 <span type="species:ncbi:9986">rabbit</span>
Commercially available slides coated with fixed HEp-2 cells (Antibodies, Inc.) were incubated with rabbit antisera diluted 1/20 in 5% goat serum (Jackson ImmunoResearch Laboratories) for 30 min at room temperature (RT). ANA binding was detected by fluorescence microscopy following 30-min incubation at RT with 12.5 ng/microl FITC-goat anti-rabbit IgG Fc (Southern Biotechnology Associates). Secondary antibody against IgG was selected to avoid unwanted background fluorescence and positive results of doubtful clinical importance. Fluorescent binding patterns were compared with pictures in von Muhlen and Tan [21] and with reference pictures provided with the Antibodies, Inc. kit.
###end p 27
###begin title 28
Cell isolation
###end title 28
###begin p 29
Viable PBMC were isolated from heparinized blood by density gradient centrifugation on Lympholyte-Mammal (Cedarlane Laboratories Limited). This permitted recovery of lymphocytes and monocytes but eliminated most red cells and granulocytes. After isolation, cells were immediately placed on ice for flow cytometry assays or placed into TRIzoltrade mark reagent (Invitrogen) for RNA isolation.
###end p 29
###begin title 30
Flow cytometry
###end title 30
###begin p 31
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Yang1">[19]</xref>
###xml 858 859 858 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 315 321 <span type="species:ncbi:9793">donkey</span>
###xml 327 331 <span type="species:ncbi:9925">goat</span>
###xml 848 854 <span type="species:ncbi:9986">Rabbit</span>
###xml 901 905 <span type="species:ncbi:9925">goat</span>
###xml 911 917 <span type="species:ncbi:9986">rabbit</span>
Purified PBMCs were stained using standard flow cytometric methods. Briefly, cells were incubated on ice for 40 min with primary antibody before washing twice with cold PBS containing 1% FCS, then subsequent incubation with various secondary reagents or secondary antibodies [19]. For BR3 detection, a biotinylated donkey anti-goat IgG was used as secondary antibody. Biotinylated antibodies were visualized by PE-conjugated streptavidin (Jackson ImmunoResearch Laboratories, Inc). After washing, cells were analyzed using a FACS-Calibur flow cytometer (BD Pharmingen) and FlowJo analytical software (Tree Star). Cells were gated on side scatterxforward scatter (SSCxFSC) profiles to include both small and large lymphocytes, as well as monocytes but exclude red blood cells and granulocytes; dead cells were excluded by propidium iodide staining. Rabbit IgM+ B cells were detected by FITC-conjugated goat anti-rabbit IgM (Southern Biotechnology Associates).
###end p 31
###begin title 32
Detection of expression levels of BAFF, BR3 and other mRNA
###end title 32
###begin p 33
Viable PBMC isolated from heparinized blood by density gradient centrifugation on Lympholyte-Mammal (Cedarlane Laboratories Limited) were immediately placed in TRIzol reagent after isolation, homogenized and filtered with Qiashredder column (Qiagen). Total RNA was isolated by RNeasy spin column (Qiagen) and precipitated with ethanol. First-stand cDNA was synthesized using the SuperScript.
###end p 33
###begin p 34
###xml 626 633 623 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t002">Table 2</xref>
###xml 410 416 <span type="species:ncbi:9986">rabbit</span>
###xml 542 549 <span type="species:ncbi:9986">rabbits</span>
###xml 946 953 <span type="species:ncbi:9986">rabbits</span>
First-strand synthesis kit (Invitrogen). Quantitative PCR to determine the relative expression levels of BAFF, BR3 and other mRNAs was performed on 9700HT Sequence Detection System (Applied Biosystems). Synthesized cDNA from isolated PBMCs was directly used as template for real-time PCR by using TaqMan 2x PCR Master Mix Reagents Kit (Applied Biosystems). Relative expression levels of an additional mRNA for rabbit beta2-microglobulin (B2M) found in earlier studies (Rai et al. ms in preparation) to be elevated in expression in some lupus rabbits was also measured. The primers, probes and PCR conditions used are shown in Table 2. Each sample from three independent experiments was run in duplicate. The unit number showing relative mRNA levels in each sample was determined as a value of mRNA normalized against peptidylprolyl isomerase A (PPIA). Previous studies showed uniform expression of PPIA in total WBCs from both normal and treated rabbits (Rai et al. ms in preparation).
###end p 34
###begin title 35
###xml 57 63 <span type="species:ncbi:9986">rabbit</span>
Primers and probes for quantitation of mRNA by Q-PCR for rabbit BAFF, BR3, PPIA control and beta2 microglobulin (B2M).
###end title 35
###begin p 36
The total volume of PCR reaction was 25 microl and the PCR conditions were as follows: 50degreesC for 2 min, 95degreesC for 10 min, followed by 40 cycles of 95degreesC, 15 s for denaturation and 60degreesC, 1 min for annealing and extension.
###end p 36
###begin title 37
Statistical analysis
###end title 37
###begin p 38
Student's t test, Pearson's correlation analysis and ANOVA procedures were performed using SAS v8.0, JMP-7 and Prism software to examine associations of BAFF, BR3, and TACI measurements with antibody responses and hematological data.
###end p 38
###begin title 39
Results
###end title 39
###begin title 40
Clinical findings and leukocyte responses
###end title 40
###begin p 41
###xml 67 70 67 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 72 75 72 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 291 299 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s001">Table S1</xref>
###xml 783 784 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 895 897 891 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 929 930 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1155 1156 1147 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1261 1263 1249 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1269 1271 1257 1259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1353 1355 1341 1343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1361 1363 1349 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1457 1465 1445 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s001">Table S1</xref>
###xml 1580 1583 1568 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 29 36 <span type="species:ncbi:9986">rabbits</span>
###xml 580 587 <span type="species:ncbi:9986">rabbits</span>
###xml 603 610 <span type="species:ncbi:9986">rabbits</span>
###xml 946 953 <span type="species:ncbi:9986">rabbits</span>
###xml 1665 1668 <span type="species:ncbi:31658">CFA</span>
###xml 1831 1833 <span type="species:ncbi:9986">CF</span>
###xml 1926 1929 <span type="species:ncbi:31658">CFA</span>
###xml 1998 2005 <span type="species:ncbi:9986">rabbits</span>
###xml 2088 2093 <span type="species:ncbi:9606">human</span>
###xml 2147 2150 <span type="species:ncbi:31658">CFA</span>
As in the previously studied rabbits that developed autoantibodies [5], [9], no evidence of kidney damage or pathology was seen in the present group. However, as observed in the 5th group [9], hematological profiles suggested development of chronic inflammatory responses. Supporting online Table S1 summarizes observed changes in total White Blood Cell (WBC), Monocyte, Neutrophil, Eosinophil and Basophil counts after immunization. Values in bold face are above the normal reference range shown in the footnote to the table. With the exception of two Freund's immunized control rabbits (CF3 and CF4), rabbits developed higher WBC counts by the third or fifth boost with many above the normal reference range. Total WBC counts were elevated above the normal reference range (4-10x103/microl) in two littermates (BB 74 and CF1) prior to immunization (pre) and became further elevated after the 3rd boost. The mean WBC counts (x103/microl) in all rabbits prior to immunization were 7.30+/-1.71 (SD) and rose to 11.40+/-3.17 and 11.60+/-3.12 after the third and fifth boosts. Lymphocyte numbers generally remained within the normal reference range (1.2-7x103/microl) but there were elevations in neutrophils (2.0+/-0.79 in pre and 5.9+/-2.23, 5.1, +/-2.02 after 3rd and 5th boosts) and monocytes (0.26+/-0.13 in pre and 0.65+/-0.29 and 0.57+/-0.25 after 3rd and 5th boosts). Some eosinophil and basophil counts also increased with a few shown in bold face in Table S1 exceeding the normal reference ranges (0-0.10;0-0.50). These results confirm and extend those previously reported [9] that raised the possibility that among these selectively bred pedigreed animals, CFA followed by IFA could generate the elevated leukocyte response we found after immunization with GR-MAP-8 or the branched BB-MAP-8 without additional peptide. The CF group was added to the present study because we had not previously investigated the role of CFA followed by IFA. We conclude that in some of these selectively bred rabbits, elevated leukocyte response typical of chronic inflammatory responses but not of human SLE can occur due to the immunization protocol using CFA and IFA.
###end p 41
###begin title 42
Anti-peptide and autoantibody responses
###end title 42
###begin p 43
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Table 3</xref>
###xml 92 100 92 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g001">Figure 1</xref>
###xml 556 565 556 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g001">Figure 1C</xref>
###xml 788 790 788 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 433 440 <span type="species:ncbi:9986">rabbits</span>
###xml 730 733 <span type="species:ncbi:31658">CFA</span>
Table 3 contains primary data obtained by Q-PCR, ELISA and ANA indirect immunofluorescence. Figure 1 summarizes pre-immune and post-immune measurements of anti-peptide and anti-dsDNA responses. In panels A and B, the pre-immune OD 450 nm values are shown in light blue and the responses after each boost are shown in distinct colors. The low pre-immune values were not subtracted from the post-immune values shown. Four of the eight rabbits that were immunized with GR-MAP-8 developed high anti-dsDNA by the third boost and four developed lower responses (Figure 1C). A marked increase in anti-dsDNA was measured in one animal that received MAP-8 backbone (BB86) starting after the second boost, and one animal that received only CFA followed by IFA (CF5) developed anti-dsDNA after the 5th boost.
###end p 43
###begin title 44
ELISA measurements of anti-peptide and anti-dsDNA responses.
###end title 44
###begin p 45
###xml 489 491 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 494 496 494 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 285 287 <span type="species:ncbi:9986">CF</span>
###xml 299 306 <span type="species:ncbi:9986">rabbits</span>
###xml 380 387 <span type="species:ncbi:9986">rabbits</span>
###xml 426 432 <span type="species:ncbi:9986">rabbit</span>
In panels A (anti-peptide B) and B (anti-dsDNA), the pre-immune OD 450 nm values are shown in light blue and the responses after each boost are shown in distinct colors. The low pre-immune values were not subtracted from the post-immune values shown. C. Mean responses of GR-, BB- and CF- immunized rabbits showing high and low anti-dsDNA responders (ds) among GR-MAP-8 immunized rabbits. Each symbol represents an individual rabbit serum tested prior to immunization (Pre ds), after the 3rd, 5th and intravenous (iv) boosts.
###end p 45
###begin title 46
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt102">*</xref>
Summary of mRNA expression data and autoantibody responses.*
###end title 46
###begin p 47
Bold shows values of at least 0.1 (for ELISA) or 1 [for Q-PCR and ANA (IFA)] above the pre-immune values. Italics show values of at least 1 (for Q-PCR) below pre-immune values.
###end p 47
###begin p 48
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g002">Figure 2</xref>
###xml 420 422 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 528 531 524 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 533 536 529 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 853 856 849 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 996 1004 992 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s001">Table S1</xref>
###xml 1189 1197 1185 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g003">Figure 3</xref>
###xml 1202 1209 1198 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Table 3</xref>
###xml 698 700 <span type="species:ncbi:9986">CF</span>
###xml 983 986 <span type="species:ncbi:31658">CFA</span>
###xml 1045 1052 <span type="species:ncbi:9986">rabbits</span>
###xml 1091 1093 <span type="species:ncbi:9986">CF</span>
Figure 2 shows that in contrast to anti-dsDNA responses, most pre-immune sera assayed by ELISA already had background anti-nuclear antibodies (ANA), anti-Sm and anti-RNP. All post-immunization responses are plotted as DeltaOD; the OD at 450 in post-boost sera minus the OD at 450 in pre-immune sera (these background values are shown separately in light blue). The same animal (CF5) that developed anti-dsDNA after the 5th boost also developed an elevated positive anti-RNP response at that time. As observed in earlier studies [5], [9], ANA ELISA values increased in most of the peptide immunized (GR) and backbone immunized (BB) control animals. Increases were also observed in four of the seven CF adjuvant control animals. The contribution of adjuvant treatment to autoantibody responses in this model was raised and discussed in our previous paper [9]. Not only do elevated leukocyte levels typical of chronic inflammatory responses occur due to the immunization protocol using CFA and IFA (Table S1), but in some of these selectively bred rabbits, whether exposed to peptide GR, BB or CF alone, also produce ANA measured by both ELISA and indirect immunofluorescence on HEp-2 cells (Figure 3 and Table 3).
###end p 48
###begin title 49
ELISA measurements of other autoantibody responses.
###end title 49
###begin p 50
###xml 187 194 <span type="species:ncbi:9986">rabbits</span>
The pre-immune OD 450 nm values found by ELISA for anti-nuclear antibodies (ANA), anti-Sm and anti-RNP are shown separately in light blue because of the high levels of antibodies in some rabbits prior to immunization. All post-immunization responses are given as DeltaOD (the OD 450 in post-boost sera minus the OD 450 in pre-immune sera).
###end p 50
###begin title 51
ANA indirect immunofluorescence.
###end title 51
###begin p 52
###xml 163 165 <span type="species:ncbi:9986">CF</span>
Examples of immunofluorescent staining results using pre and post-immune sera from pairs of littermates selected from GR-peptide, BB control and adjuvant control (CF) animals.
###end p 52
###begin p 53
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g003">Figure 3</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-vonMhlen1">[21]</xref>
###xml 373 381 373 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g003">Figure 3</xref>
###xml 713 716 713 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 718 721 718 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 1002 1006 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Servais1">[22]</xref>
###xml 1116 1120 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Servais1">[22]</xref>
###xml 1264 1272 1264 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g003">Figure 3</xref>
###xml 1412 1414 1412 1414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1451 1453 1451 1453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1494 1496 1494 1496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 2148 2150 2148 2150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 200 202 <span type="species:ncbi:9986">CF</span>
###xml 769 777 <span type="species:ncbi:9606">patients</span>
###xml 802 809 <span type="species:ncbi:9606">patient</span>
###xml 846 854 <span type="species:ncbi:9606">patients</span>
###xml 1069 1077 <span type="species:ncbi:9606">patients</span>
###xml 1108 1115 <span type="species:ncbi:9606">patient</span>
###xml 2166 2171 <span type="species:ncbi:9606">human</span>
###xml 2176 2184 <span type="species:ncbi:9606">patients</span>
###xml 2270 2277 <span type="species:ncbi:9986">rabbits</span>
Figure 3 shows examples of test results for ANA detected by indirect immunofluorescence on HEp-2 cells, in pre-immune and post immune sera from litter-mate pairs representing four GR- two BB- and two CF-immunized animals. Fluorescent binding patterns were compared with pictures in [21] and with reference pictures provided with the Antibodies, Inc. kit. Patterns shown in Figure 3 include homogeneous and peripheral nuclear, speckled, cytoplasmic, and nucleolar staining. We previously noted that ANA indirect immunofluorescent staining patterns using sera from BB immunized animals generally differed from those of GR immunized animals, but in those studies the contribution of adjuvant alone was not evaluated [5], [9]. A retrospective study of 690 sera from 58 SLE patients and1187 sera from other patient controls, reported that sera of SLE patients with high levels of anti-dsDNA did not necessarily exhibit homogeneous staining but were also found associated with speckled or nucleolar patterns [22]. They reported that patterns of ANA staining with sera of SLE patients were typical for a particular patient [22]. We therefore chose examples of results of ANA indirect immunofluorescence tests of pre-immune and post immune sera from pairs of littermates (Figure 3). Littermates UA269-3 and -1 were both GR immunized (GR73 and GR77). The peripheral nuclear staining patterns of both appeared similar at 3rd boost and GR73 remained similar at 5th boost. However staining intensity with 5th boost serum of GR77 increased and the pattern appeared speckled. GR85 and BB82 (XA346-1 and 2) exhibited distinct staining patterns with GR85 showing some cytoplasmic and peripheral nuclear staining not seen in its BB-immunized BB82; littermates GR80 and CF5 (XA345-1 and -2) both exhibited only minimal ANA staining although CF5 that produced some anti-dsDNA after the fifth boost also developed increased ANA fluorescence with some nucleolar staining. Finally, background pre-immune ANA peripheral nuclear staining with sera of littermates BB75 and CF4 (2YA125-6 and -4) remained the same although it became slightly more intense in BB75 after the 3rd boost. As with human SLE patients, we found IFA patterns reflecting responses to one or more autoantigens in different rabbits.
###end p 53
###begin title 54
Analyses of BAFF, BR3 and TACI by flow cytometry
###end title 54
###begin p 55
###xml 75 83 75 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s002">Table S2</xref>
###xml 142 150 142 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g004">Figure 4</xref>
###xml 238 247 238 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g004">Figure 4A</xref>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Yang1">[19]</xref>
###xml 577 578 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 650 659 650 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g004">Figure 4A</xref>
###xml 801 805 801 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 813 816 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 822 830 822 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s002">Table S2</xref>
###xml 901 902 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 907 911 907 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 919 922 919 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 1219 1227 1219 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s002">Table S2</xref>
###xml 1325 1334 1325 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g004">Figure 4B</xref>
###xml 1409 1411 1409 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1638 1646 1638 1646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s002">Table S2</xref>
###xml 1649 1658 1649 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g004">Figure 4C</xref>
###xml 1762 1763 1762 1763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1813 1814 1813 1814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1981 1982 1981 1982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1995 1996 1995 1996 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2001 2002 2001 2002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2229 2237 2229 2237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s002">Table S2</xref>
###xml 524 531 <span type="species:ncbi:9986">rabbits</span>
###xml 730 736 <span type="species:ncbi:9986">rabbit</span>
###xml 1542 1549 <span type="species:ncbi:9986">rabbits</span>
The set of data collected is tabulated as supplemental online information (Table S2). Examples of flow cytometry (FACS) profiles are shown in Figure 4. In the table, "total cells" refers to all live cells in the lymphocyte monocyte gate (Figure 4A left panel). Cells were gated on side scatterxforward scatter (SSCxFSC) profiles to include both small and large lymphocytes as well as monocytes but to exclude red blood cells and granulocytes. We analyzed CD14+ cells because in our previous report on BAFF and BR3 in normal rabbits [19], we showed that in PBMC, it was the CD14+ cells that expressed high levels of BAFF mRNA. In the example shown in Figure 4A, right panel, IgM staining of the gated cells from pre-immune PBMC of rabbit GR84 shows that two positive cell populations were observed (IgMhigh and IgMlow). In Table S2, percentages and median fluorescent intensities (MFI) shown are of IgM+ (IgMhigh and IgMlow) cells because it is not always possible to clearly delineate the two populations. Percentages of cells positive by FACS and their median fluorescence intensities shown permit comparisons of staining results on pre-immune samples (Pre) with results on samples after 3rd and 5th boosts. Colors in Table S2 highlight values that increased (orange), or decreased (blue), compared to pre-immune values. In Figure 4B, the histograms show the staining of total PBMC from pre-immune and post 3rd boost of GR-immunized anti-dsDNA high responder (GR72) and low responder (GR84) for BAFF or BR3 and the control antibody. In both rabbits percentages of BAFF and BR3 positive cells decreased or remained essentially unchanged (Table S2). Figure 4C (upper two rows) shows representative results of double staining for BAFF or TACI on the surface of IgM+ cells from PBMC and for BAFF, TACI or BR3 on CD14+ cells from the same high (GR72) and low (GR84) responders (lower three rows). Percentages of cells in individual quadrants are indicated. The percentages of total BR3+ PBMC and BR3+ CD14+ cells in PBMC detected by FACS increased in two of four high anti-dsDNA responder animals (GR77 and GR80). Median fluorescence intensities (MFI) of staining, although very low, also increased on cells of the same two animals (Table S2).
###end p 55
###begin title 56
Typical profiles from flow cytometry measurements.
###end title 56
###begin p 57
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 141 145 141 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 245 247 245 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 717 718 717 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 333 340 <span type="species:ncbi:9986">rabbits</span>
###xml 444 448 <span type="species:ncbi:9925">goat</span>
###xml 469 473 <span type="species:ncbi:9925">goat</span>
A. PBMCs were gated based on forward and side scatter (FSCxSSC) profiles (left panel). IgM+ cells in peripheral blood can be divided into IgMhigh and IgMlow cell populations (right panel). B. Representative plots from pre-immune (Pre) and post 3rd boost (>3B) analyses of GR anti-dsDNA high responder (GR72) and low responder (GR84) rabbits. The histograms show the staining of total PBMC for BAFF and BR3 and the control biotin-labeled normal goat IgG for BAFF normal goat IgG for BR3 (shaded). C. Representative dot plots from GR anti-dsDNA high responder (GR72) and low responder (GR84). The plots showed the staining of BAFF and TACI on the surface of peripheral blood IgM+ cells and of BAFF, TACI and BR3 on CD14+ cells.
###end p 57
###begin p 58
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s002">Table S2</xref>
###xml 136 144 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g004">Figure 4</xref>
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Table 3</xref>
###xml 229 237 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g005">Figure 5</xref>
###xml 388 390 <span type="species:ncbi:9986">CF</span>
###xml 752 759 <span type="species:ncbi:9986">rabbits</span>
In order to provide an overview of FACS analyses of BAFF, TACI and BR3 on total PBMC, or CD14+ cell populations from PBMC (Table S2 and Figure 4) and results of measurements of BAFF and BR3 mRNA in total PBMC by Q-PCR (Table 3), Figure 5 shows results pre-immunization and after the third boost grouped according to high and low anti-dsDNA responses of GR-immunized compared with BB- and CF- immunized animals. Percentages of BAFF positive cells and MFI generally remained unchanged or decreased in all the immunized groups but a decrease was most consistent in the high anti-dsDNA responder animals. Another consistent change observed by FACS staining was in TACI. Percentages and MFI of TACI staining of total PBMC decreased in most of the immunized rabbits in all groups.
###end p 58
###begin title 59
Summary of BAFF and BR3 mRNA expression by Q-PCR, BAFF, BR3, and TACI expression by FACS.
###end title 59
###begin p 60
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 320 327 320 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Table 3</xref>
###xml 631 639 631 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s002">Table S2</xref>
###xml 644 652 644 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g004">Figure 4</xref>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 872 873 872 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 953 954 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1000 1001 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1006 1007 1006 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1075 1076 1075 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 112 114 <span type="species:ncbi:9986">CF</span>
###xml 125 132 <span type="species:ncbi:9986">rabbits</span>
###xml 1149 1151 <span type="species:ncbi:9986">CF</span>
Plotted are means and SEM of results comparing high and low anti-dsDNA responders of GR- immunized with BB- and CF-immunized rabbits (anti-dsDNA OD at 450 nm as determined by ELISA). This overview summarizes results of measurements of pre-immune (Pre) and post boost 3 (3rd) BAFF and BR3 mRNA in total PBMC by Q-PCR [in Table 3, the unit number showing relative mRNA levels in each sample was determined as a value of mRNA normalized against peptidylprolyl isomerase A (PPIA)]. The figure also shows means and SEM of results of FACS analyses of percentages of cells and median fluorescence intensities (MFI) of BAFF, TACI and BR3 (Table S2 and Figure 4) on total PBMC, or CD14+ cell populations from PBMC (the bars are not stacked). In the GR high anti-dsDNA responders, three way ANOVA with repeated measures indicated significant decreases in percentages and MFI of BAFF+ cells among total PBMC (p 0.015 and 0.0002 respectively) as well as MFI on CD14+ cells (p 0.012). Decreased percentage of BAFF+ CD14+ cells was near significance (p 0.06). Decreased percentages of TACI+ cells among PBMC were significant or near significant in GR low, BB and CF groups (p 0.03, 0.013, 0.09 respectively); decreased TACI MFI were also near significant or significant (0.06, 0.07 and 0.03 respectively).
###end p 60
###begin title 61
Q-PCR analyses of BAFF, BR3 and B2M expression
###end title 61
###begin p 62
###xml 86 93 86 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Table 3</xref>
###xml 98 106 98 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g005">Figure 5</xref>
###xml 319 326 319 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Table 3</xref>
###xml 331 339 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g005">Figure 5</xref>
###xml 582 589 582 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Table 3</xref>
###xml 77 84 <span type="species:ncbi:9986">rabbits</span>
###xml 135 137 <span type="species:ncbi:9986">CF</span>
###xml 346 353 <span type="species:ncbi:9986">rabbits</span>
###xml 542 549 <span type="species:ncbi:9986">rabbits</span>
BR3 mRNA levels decreased after the third boost in six of eight GR-immunized rabbits (Table 3 and Figure 5). BR3 mRNA levels in BB and CF immunized also decreased slightly in most animals. The levels of BAFF mRNA in PBMC pre-immunization and in cells collected after the 3rd boost generally remained low and unchanged (Table 3 and Figure 5). Two rabbits (GR84 and 85) that exhibited low anti-dsDNA responses had increased BAFF mRNA after the 3rd boost. In each group, increased levels of mRNA encoding B2M were found in half of the immunized rabbits after the third or fifth boost (Table 3).
###end p 62
###begin p 63
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g005">Figure 5</xref>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 155 162 155 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Table 3</xref>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 319 327 319 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008494.s002">Table S2</xref>
###xml 332 340 332 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g004">Figure 4</xref>
###xml 482 483 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 563 564 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 610 611 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 616 617 616 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 685 686 685 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 759 761 <span type="species:ncbi:9986">CF</span>
Figure 5 provides an overview that summarizes results of measurements of pre-immune (Pre) and post boost 3 (3rd) BAFF and BR3 mRNA in total PBMC by Q-PCR (Table 3), FACS analyses of percentages of cells and median fluorescence intensities (MFI) of BAFF, TACI and BR3 on total PBMC, or CD14+ cell populations from PBMC (Table S2 and Figure 4). In the GR high anti-dsDNA responders, three way ANOVA with repeated measures indicated significant decreases in percentages and MFI of BAFF+ cells among total PBMC (p 0.015 and 0.0002 respectively) as well as MFI on CD14+ cells (p 0.012). Decreased percentage of BAFF+ CD14+ cells was near significance (p 0.06). Decreased percentages of TACI+ cells among PBMC were significant or near significant in GR low, BB and CF groups (p 0.03, 0.013, 0.09 respectively); decreased TACI MFI were also near significant or significant (p 0.06, 0.07 and 0.03 respectively).
###end p 63
###begin title 64
Summary of autoantibody responses and pedigree
###end title 64
###begin p 65
###xml 123 126 123 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008494-g006">Figure 6</xref>
###xml 205 208 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 467 470 467 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Rai1">[5]</xref>
###xml 549 552 549 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 772 773 772 773 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</monospace>
###xml 374 381 <span type="species:ncbi:9986">rabbits</span>
###xml 684 686 <span type="species:ncbi:9986">CF</span>
###xml 809 816 <span type="species:ncbi:9986">rabbits</span>
A pedigree showing summaries of the responses of selected animals from five previous immunization groups 1-5 was published [9]. Figure 6 shows the present group 6 added on to ancestors reported previously [5], [9] and summarizes their autoantibody responses. Responders such as GR72, 73, 76,77 and 85 can trace relationships in their pedigree back to key founders including rabbits that exhibited seizures (SM1, GR9), and high responder males including SM13 and SM15 [5]. The trend toward more consistent autoantibody production observed in group 5 [9], continues here. Immunization of relatives of GR peptide immunized animals with Freund's complete followed by incomplete adjuvant (CF group) or with backbone alone (BB group) did elicit some production of autoantibodies. This suggests that in this line of rabbits, some have developed susceptibility to development of autoantibodies regardless of the immunogen. However, inclusion of the eight copies of GR peptide on the backbone of branched polylysine (GR-MAP-8) more consistently elicited autoantibody production.
###end p 65
###begin title 66
Pedigree and summary of autoantibody responses.
###end title 66
###begin p 67
###xml 458 461 458 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Puliyath1">[9]</xref>
###xml 543 551 543 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008494-t003">Tables 3</xref>
###xml 156 163 <span type="species:ncbi:9986">rabbits</span>
An overview of key ancestors, autoantibody responses, and the relationship of males (large squares) and females (large circles) in the current (group 6) to rabbits in 5 earlier groups is shown. Colors in the four quadrants indicate postimmunization elevations of levels of anti-dsDNA (blue, upper left), anti-Sm and/or anti-RNP (yellow, lower left), ANA by IFA (red upper right) and ANA by ELISA (brown diagonal lines, lower right). For the previous group 5 [9] and present group 6 animals, darker colors indicate high autoantibody responses (Tables 3).
###end p 67
###begin title 68
Discussion
###end title 68
###begin p 69
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Yang1">[19]</xref>
###xml 4 10 <span type="species:ncbi:9986">rabbit</span>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 184 190 <span type="species:ncbi:9986">rabbit</span>
###xml 556 562 <span type="species:ncbi:9986">rabbit</span>
###xml 629 636 <span type="species:ncbi:9986">rabbits</span>
###xml 643 648 <span type="species:ncbi:9606">Human</span>
###xml 773 778 <span type="species:ncbi:9606">human</span>
The rabbit has long been a model for human autoimmune and infectious diseases. It is now increasing in importance because the genetics of the immune system is well defined, the entire rabbit genome has been sequenced and a high quality draft assembly (7x coverage) was completed in April 2009 (GenBank Accession Number AAGW02000000). The assembly of the 2x coverage completed in 2005 plus the 7x trace archive already provided useful information that has contributed to the present report and the previous one that described expression and localization of rabbit BAFF and its specific receptor BR3 in cells and tissues of normal rabbits [19]. Human disease models developed in non-inbred but genetically defined animals are better able to reflect the complexities of those human diseases with familial patterns of inheritance due to variants of genes at numerous loci with potential to contribute to the disease phenotype. Systemic Lupus Erythematosus and other autoimmune diseases are in this category. Our model of SLE that elicits autoantibodies after immunization with a peptide from the NMDA glutamate receptor, can provide a means for development of further insights into neuropsychiatric lupus, and pursuit of therapeutic targets.
###end p 69
###begin p 70
###xml 85 91 <span type="species:ncbi:9986">rabbit</span>
###xml 307 313 <span type="species:ncbi:9986">rabbit</span>
Limitations were imposed upon the work presented here because there are currently no rabbit-specific reagents for BAFF and its receptors available. We therefore had to discover and utilize cross-reactive antibodies. This decreased sensitivity of analyses and quantitation by FACS. Fortunately, sequences of rabbit BAFF, BR3 and B2M allowed us to conduct successful quantitative PCR measurements of mRNA levels in PBMC.
###end p 70
###begin p 71
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Schiemann1">[23]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-ShulgaMorskaya1">[24]</xref>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 707 708 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 708 712 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Raman1">[26]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Pospisil1">[27]</xref>
###xml 739 740 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 833 834 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Pospisil2">[28]</xref>
###xml 958 962 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Pospisil3">[29]</xref>
###xml 1015 1019 1015 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Yang1">[19]</xref>
###xml 1107 1108 1107 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 53 59 <span type="species:ncbi:9606">humans</span>
###xml 252 258 <span type="species:ncbi:9986">rabbit</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 612 617 <span type="species:ncbi:10090">mouse</span>
###xml 622 627 <span type="species:ncbi:9606">human</span>
###xml 649 656 <span type="species:ncbi:9986">rabbits</span>
###xml 729 735 <span type="species:ncbi:9986">rabbit</span>
###xml 783 789 <span type="species:ncbi:10090">murine</span>
###xml 823 829 <span type="species:ncbi:9986">rabbit</span>
###xml 855 860 <span type="species:ncbi:9606">human</span>
###xml 865 870 <span type="species:ncbi:10090">mouse</span>
###xml 922 928 <span type="species:ncbi:9986">rabbit</span>
###xml 1034 1041 <span type="species:ncbi:9986">rabbits</span>
###xml 1200 1207 <span type="species:ncbi:9986">rabbits</span>
Just as there are known differences between mice and humans in details of the effects of BAFF and its receptors on B-cell subsets, and their regulated development, there are likely to be additional species-specific aspects of the complex regulation of rabbit B- cell development including involvement of BAFF, BR3, TACI, APRIL and BCMA. Although BAFF is essential for development and maintenance of most B-cells, CD5-positive B-1 cells develop in mice lacking BAFF or BR3 [23], [24]. However, it has more recently been observed that BAFF does stimulate mouse B1 B cells (25). Although only a small proportion of mouse and human B cells are CD5+, in rabbits the majority of B cells as well as T cells are CD5+[26], [27]. However, rabbit CD5+ B cells are not functional equivalents of murine B-1 B-cells and some features of rabbit CD5+ B cells differ from human and mouse [28]. It also appears that the CD5 associated with rabbit B- and T-lymphocytes differs [29]. Immunohistochemical studies of spleens from normal [19] and immunized rabbits (data not shown) detected BAFF staining on large CD4+ T cells IgM+ B cells, but we did not detect differences in CD5 staining in immunized compared to normal rabbits.
###end p 71
###begin p 72
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Yang1">[19]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Darce1">[30]</xref>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Carter1">[31]</xref>
###xml 1221 1222 1221 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1227 1228 1227 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1233 1234 1233 1234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1239 1240 1239 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1257 1258 1257 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1650 1654 1650 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Beutler1">[32]</xref>
###xml 1718 1721 1718 1721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 208 214 <span type="species:ncbi:9986">rabbit</span>
###xml 345 350 <span type="species:ncbi:9606">human</span>
###xml 583 586 <span type="species:ncbi:9606">man</span>
###xml 659 666 <span type="species:ncbi:9986">rabbits</span>
###xml 743 750 <span type="species:ncbi:9986">rabbits</span>
###xml 863 870 <span type="species:ncbi:9986">rabbits</span>
###xml 1161 1168 <span type="species:ncbi:9986">rabbits</span>
###xml 1722 1728 <span type="species:ncbi:9986">rabbit</span>
Another major limitation has been our inability to detect serum BAFF with currently available cross-reacting reagents. We previously demonstrated that BAFF mRNA was not detectable in IgM+ B cells from normal rabbit PBL suggesting that BAFF detected by flow cytometry on the B cells was probably soluble BAFF bound to BAFF receptors [19]. Normal human peripheral blood B cells and tonsillar naive and memory B cells were found to have pre-bound BAFF although tonsillar activated B cells did not [30]. Higher occupancy of BR3 by BAFF was reported to correlate with disease activity in man [31]. The BAFF staining on B cells in peripheral blood and spleens from rabbits producing autoantibodies may either reflect BAFF produced by the B cells of rabbits with lupus-like autoantibodies or again be bound through BAFF receptors on B cells. In those GR high anti-dsDNA rabbits in which BAFF detected on PBMC decreased significantly, perhaps less pre-bound BAFF was present on BR3 or other receptors. Although surface expression of BAFF, BR3 and TACI detected by flow cytometry decreased on PBMC after immunization and boosting in most animals, two GR high anti-dsDNA rabbits (GR76 and GR77) developed higher percentages of BAFF+ CD14+, BR3+ CD14+, as wells as BR3+ cells among total PBMC. Conceivably occupancy of BR3 by soluble BAFF may block access to BR3 by anti-BR3 antibody on large activated PBMC. CD14 is found on the surface of peripheral blood monocytes and macrophages, acts as a co-receptor for detection of bacterial lipopolysaccharide (LPS), and mediates innate immune responses to LPS leading to cytokine secretion and inflammatory responses [32]. Our FACS data also showed that CD14 is also found on large IgMlow rabbit B cells (data not shown).
###end p 72
###begin p 73
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Seshasayee1">[33]</xref>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-vonBlow1">[34]</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Salzer1">[35]</xref>
###xml 512 532 512 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Mackay1">[and reviewed in 36]</xref>
###xml 152 158 <span type="species:ncbi:9986">rabbit</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 356 361 <span type="species:ncbi:9606">human</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
###xml 614 620 <span type="species:ncbi:9606">humans</span>
###xml 630 636 <span type="species:ncbi:9986">rabbit</span>
We observed consistently lower TACI percentages and MFI on total PBMC by FACS in most injected animal after their third boosts. It could be that in the rabbit, TACI also plays a negative regulatory role as observed in mice [33]. Other functions of TACI in mice include regulation of the T-independent humoral responses [34]. More complex roles for TACI in human peripheral B-cell development, class switch recombination and terminal differentiation were suggested by discoveries of TACI deficient patients [35], [and reviewed in 36]. Since TACI appears to function like a negative regulator of B cells in mice and humans, in this rabbit model of SLE, perhaps the decrease in TACI allows the autoreactive B cells to escape selection/regulation and thereby, produce auto-antibodies.
###end p 73
###begin p 74
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Ingold1">[37]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Bossen1">[38]</xref>
###xml 46 52 <span type="species:ncbi:9986">rabbit</span>
We were unable to address roles for potential rabbit homologs of APRIL and BCMA. APRIL is the TNF family member most closely related to BAFF. APRIL also binds TACI and BCMA and is expressed by lymphoid cells and some tumor cells. Recently Ingold et al [37] proposed that proteoglycans such as syndecan are APRIL-specific receptors that bind APRIL, induce oligomerization prior to the interaction of APRIL with TACI or BCMA to initiate survival signals. Additional complexities are likely due to different forms (alternatively spliced, trimer, 60-mer of BAFF plus heteromeric forms of BAFF with APRIL) interacting with the different receptors for BAFF. Bossen et al [38] reported that although BAFF-R and TACI can provide B cells with similar signals, only BAFF-R, but not TACI, can respond to soluble BAFF trimer. They found that BAFF 60-mer was more than 100-fold more active than BAFF 3-mer for the activation of multimerization-dependent signals.
###end p 74
###begin p 75
###xml 123 129 <span type="species:ncbi:9986">rabbit</span>
###xml 190 196 <span type="species:ncbi:9986">rabbit</span>
###xml 279 286 <span type="species:ncbi:9986">rabbits</span>
###xml 503 509 <span type="species:ncbi:9986">Rabbit</span>
###xml 558 564 <span type="species:ncbi:9986">Rabbit</span>
It is hoped that the limitations we encountered in working with few available reagents to detect cells and proteins of the rabbit immune system will diminish and companies will produce more rabbit-specific reagents because there is an increasing community of researchers who use rabbits for research on autoimmune, infectious, neurological, cardiovascular, ocular and other diseases. Using the new NIH research portfolio online reporting tool (RePORT) , 424 current projects match the search criteria: "Rabbit, Fiscal Year: Current Projects". See also, "The Rabbit in Immunology & Infectious Disease Research" at: .
###end p 75
###begin p 76
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Petri1">[14]</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008494-Furie1">[16]</xref>
###xml 52 59 <span type="species:ncbi:9986">rabbits</span>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 129 136 <span type="species:ncbi:9606">patient</span>
The differences we have observed between individual rabbits mirror similar heterogeneity of populations of lupus patients. Large patient populations were required in order to detect some correlations between BAFF expression, autoantibody production, and disease status [14]-[16].
###end p 76
###begin p 77
###xml 101 107 <span type="species:ncbi:9986">rabbit</span>
###xml 305 312 <span type="species:ncbi:9986">rabbits</span>
This study confirms and extends evidence for a genetic contribution to autoantibody responses in the rabbit SLE model we developed. In spite of the complexities of interactions of multiple receptors and ligands in the BAFF system discussed above, future gene expression analyses of cells and tissues from rabbits with induced autoantibody production may reveal dysregulated pathways that permit autoantibody-producing B cells to survive.
###end p 77
###begin title 78
Supporting Information
###end title 78
###begin p 79
(0.12 MB DOC)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
Summary of FACS data
###end p 81
###begin p 82
(0.11 MB PDF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
We would like to thank Cornelius Alexander, Rami Zahr and Folake Soetan for technical assistance, Jeff Skinner for advice and assistance with statistical analyses, Drs. Geeta Rai, Michael Mage, and Christoph Rader for helpful comments about the manuscript and Shirley Starnes for editorial assistance in preparation of the manuscript.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
Developments in the scientific understanding of lupus.
###end article-title 86
###begin article-title 87
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.
###end article-title 87
###begin article-title 88
Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy.
###end article-title 88
###begin article-title 89
B-cell-targeted therapy for systemic lupus erythematosus: an update.
###end article-title 89
###begin article-title 90
###xml 123 130 <span type="species:ncbi:9986">rabbits</span>
Models of systemic lupus erythematosus: Development of autoimmunity following peptide immunizations of noninbred pedigreed rabbits.
###end article-title 90
###begin article-title 91
Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity.
###end article-title 91
###begin article-title 92
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus.
###end article-title 92
###begin article-title 93
Immunity and acquired alterations in cognition and emotion: lessons from SLE.
###end article-title 93
###begin article-title 94
###xml 55 61 <span type="species:ncbi:9986">rabbit</span>
Genetic contributions to the autoantibody profile in a rabbit model of systemic lupus erythematosus (SLE).
###end article-title 94
###begin article-title 95
The BLyS family: toward a molecular understanding of B cell homeostasis.
###end article-title 95
###begin article-title 96
TACI attenuates antibody production costimulated by BAFF-R and CD40.
###end article-title 96
###begin article-title 97
BCMA is essential for the survival of long-lived bone marrow plasma cells.
###end article-title 97
###begin article-title 98
BAFF and MyD88 signals promote a lupuslike disease independent of T cells.
###end article-title 98
###begin article-title 99
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
###end article-title 99
###begin article-title 100
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus.
###end article-title 100
###begin article-title 101
###xml 157 165 <span type="species:ncbi:9606">patients</span>
Belimumab Study Group. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus. erythematosus.
###end article-title 101
###begin article-title 102
The role of B lymphocyte stimulator [BLyS) in systemic lupus erythematosus.
###end article-title 102
###begin article-title 103
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.
###end article-title 103
###begin article-title 104
###xml 31 37 <span type="species:ncbi:9986">rabbit</span>
###xml 128 134 <span type="species:ncbi:9986">rabbit</span>
Expression and localization of rabbit B-cell activating factor [BAFF) and its specific receptor BR3 in cells and tissues of the rabbit immune system.
###end article-title 104
###begin article-title 105
###xml 46 53 <span type="species:ncbi:9986">rabbits</span>
B cell and antibody repertoire development in rabbits: the requirement of gut-associated lymphoid tissues.
###end article-title 105
###begin article-title 106
Autoantibodies in the diagnosis of systemic rheumatic diseases.
###end article-title 106
###begin article-title 107
Anti DNA antibodies are not restricted to a specific pattern of fluorescence on HEp-2 cells.
###end article-title 107
###begin article-title 108
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.
###end article-title 108
###begin article-title 109
: B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.
###end article-title 109
###begin article-title 110
BAFF costimulation of Toll-like receptor-activated B-1 cells.
###end article-title 110
###begin article-title 111
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 50 56 <span type="species:ncbi:9986">rabbit</span>
CD5+ B cells predominate in peripheral tissues of rabbit.
###end article-title 111
###begin article-title 112
###xml 50 56 <span type="species:ncbi:9986">rabbit</span>
Stable expression of the extracellular domains of rabbit recombinant CD5: development and characterization of polyclonal and monoclonal antibodies.
###end article-title 112
###begin article-title 113
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 44 50 <span type="species:ncbi:9986">rabbit</span>
CD5+ B cells are preferentially expanded in rabbit appendix: the role of CD5 in B cell development and selection.
###end article-title 113
###begin article-title 114
###xml 20 26 <span type="species:ncbi:9986">rabbit</span>
Characterization of rabbit CD5 isoforms.
###end article-title 114
###begin article-title 115
###xml 54 59 <span type="species:ncbi:9606">human</span>
Regulated expression of BAFF-binding receptors during human B cell differentiation.
###end article-title 115
###begin article-title 116
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
###end article-title 116
###begin article-title 117
Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases.
###end article-title 117
###begin article-title 118
Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.
###end article-title 118
###begin article-title 119
Regulation of the T-Independent Humoral Response by TACI.
###end article-title 119
###begin article-title 120
TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency.
###end article-title 120
###begin article-title 121
TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
###end article-title 121
###begin article-title 122
Identification of proteoglycans as the APRIL-specific binding partners.
###end article-title 122
###begin article-title 123
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
###end article-title 123
###begin p 124
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 124
###begin p 125
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by the intramural research program of the NIH, NIAID () and the Oak Ridge Associated Universities (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 125

